Food Effect Bioavailability Study of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets
Status:
Not yet recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
An open label, randomized, two-period, two-treatment [Treatment A (Investigational product
administration under fasting condition) vs Treatment B (Investigational product
administration under fed condition)], two-sequence, crossover, balanced, single dose oral
food effect bioavailability study.